The anti-senescence activity of trefoil factor 1
三叶因子1的抗衰老活性
基本信息
- 批准号:8633424
- 负责人:
- 金额:$ 30.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressBinding ProteinsBiological ModelsCancerousCell AgingCell Surface ReceptorsCell membraneCellsClonal ExpansionDevelopmentEGF geneEpidermal Growth Factor ReceptorEpigenetic ProcessEventGeneticHumanInflammationLesionMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of pancreasMalignant neoplasm of prostateMediatingModelingMolecularNatureOncogene ActivationOncogenesOncogenicOrganPTEN genePancreasPathway interactionsPhosphotransferasesPremalignantProcessProstateProteinsRNA InterferenceSignal PathwaySignal TransductionStagingStomachSystemTestingTissuesTumor Suppressor GenesTumor Suppressor ProteinsTumor TissueUlcerbasecancer cellcell transformationgenome wide association studygenome-widehuman TFF1 proteinmouse modeloverexpressionpancreatic tumorigenesisprostate cancer cellprostate carcinogenesisreceptor bindingsenescencetumortumor xenografttumorigenesistumorigenic
项目摘要
DESCRIPTION (provided by applicant): The primary objective of this proposal is to fully evaluate the anti-senescence activity of Trifoil Factor 1 (TFF1) in the process of pancreatic and prostate tumorigenesis in mouse models, and elucidate the signaling mechanism underlying its anti-senescent action. Cellular senescence acts as a barrier against malignant transformation, but the mechanisms associated with the overcome of senescence remain largely unknown. Thus, new information that reveals the molecular nature of such mechanisms could have a significant impact on the understanding of senescence as a critical event in the multi-step process of tumorigenesis. As a secreted protein, TFF1 functions as a tumor suppressor in the stomach by stimulating restitution of damaged tissue associated with ulceration and inflammation to reduce tumor formation. However, TFF1 is over expressed in tumor tissues from various organs, such as pancreas and prostate, where it is not normally localized, although the functional significance of this phenomenon remains poorly understood. To address this question, we investigated the function of TFF1 in the context of tumorigenesis using human pancreatic and prostate cancer cells and found that it acts to enable cells to breach the barrier of senescence induced by oncogenic Ras or reduction in tumor suppressor PTEN expression. Thus, our results indicate that in the context of pancreatic and prostate cancer, the previously defined tumor suppressor TFF1 actually promotes tumorigenesis by enabling pre-cancerous lesions to overcome the barrier of oncogene-induced senescence. To build on this unexpected discovery, we intend to fully determine the functional impact of TFF1 over expression on pancreatic and prostate tumorigenesis by employing two well-established mouse model systems in which oncogene activation-induced senescence has been thoroughly documented to act as a barrier for oncogenic transformation. In the meantime, by the identification of receptor/cell surface binding protein of TFF1 using both a candidate-approach and a RNAi-based genome-wide screen, we will test the hypothesis that TFF1 acts to suppress cellular senescence via a still undefined signaling pathway to allow clonal expansion of cells that harbor the initial genetic lesions in the early stage of tumorigenesis.
描述(由申请人提供):本提案的主要目的是在小鼠模型中全面评价三叶因子1(TFF 1)在胰腺和前列腺肿瘤发生过程中的抗衰老活性,并阐明其抗衰老作用的信号传导机制。细胞衰老作为一个屏障,以防止恶性转化,但与克服衰老的机制仍然在很大程度上是未知的。因此,揭示这种机制的分子本质的新信息可能会对理解衰老作为肿瘤发生多步骤过程中的关键事件产生重大影响。作为一种分泌蛋白,TFF 1通过刺激与溃疡和炎症相关的受损组织的恢复来减少肿瘤形成,从而在胃中起到肿瘤抑制剂的作用。然而,TFF 1在来自各种器官的肿瘤组织中过度表达,例如胰腺和前列腺,在那里它通常不定位,尽管这种现象的功能意义仍然知之甚少。为了解决这个问题,我们研究了TFF 1在肿瘤发生的背景下,使用人胰腺癌和前列腺癌细胞的功能,并发现它的作用,使细胞能够突破致癌Ras诱导的衰老屏障或肿瘤抑制基因PTEN表达的减少。因此,我们的研究结果表明,在胰腺癌和前列腺癌的背景下,以前定义的肿瘤抑制因子TFF 1实际上通过使癌前病变能够克服癌基因诱导的衰老的障碍来促进肿瘤发生。为了建立在这个意想不到的发现,我们打算充分确定功能的影响,TFF 1过度表达胰腺和前列腺肿瘤的发生,采用两个完善的小鼠模型系统,其中癌基因激活诱导的衰老已被彻底记录作为致癌转化的障碍。与此同时,通过使用候选方法和基于RNAi的全基因组筛选鉴定TFF 1的受体/细胞表面结合蛋白,我们将测试TFF 1通过尚不明确的信号通路抑制细胞衰老以允许在肿瘤发生的早期阶段具有初始遗传病变的细胞的克隆扩增的假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIAO-FAN WANG其他文献
XIAO-FAN WANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIAO-FAN WANG', 18)}}的其他基金
Roles of mitochondrial dynamics and mtDNA in senescence
线粒体动力学和 mtDNA 在衰老中的作用
- 批准号:
10641668 - 财政年份:2022
- 资助金额:
$ 30.76万 - 项目类别:
Roles of mitochondrial dynamics and mtDNA in senescence
线粒体动力学和 mtDNA 在衰老中的作用
- 批准号:
10344369 - 财政年份:2022
- 资助金额:
$ 30.76万 - 项目类别:
Roles of mitochondrial dynamics and mtDNA in senescence
线粒体动力学和 mtDNA 在衰老中的作用
- 批准号:
10795145 - 财政年份:2022
- 资助金额:
$ 30.76万 - 项目类别:
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma
NGF 招募神经纤维来重新编程黑色素瘤中的免疫抑制微环境
- 批准号:
10552544 - 财政年份:2020
- 资助金额:
$ 30.76万 - 项目类别:
Synthetic lethality by targeting the core senescent mechanism in lung cancer.
针对肺癌核心衰老机制的综合致死率。
- 批准号:
10558746 - 财政年份:2020
- 资助金额:
$ 30.76万 - 项目类别:
Synthetic lethality by targeting the core senescent mechanism in lung cancer.
针对肺癌核心衰老机制的综合致死率。
- 批准号:
10368019 - 财政年份:2020
- 资助金额:
$ 30.76万 - 项目类别:
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma
NGF 招募神经纤维来重新编程黑色素瘤中的免疫抑制微环境
- 批准号:
10321215 - 财政年份:2020
- 资助金额:
$ 30.76万 - 项目类别:
Targeting UHRF1 in combinational immunotherapy
联合免疫治疗中的靶向 UHRF1
- 批准号:
10308390 - 财政年份:2019
- 资助金额:
$ 30.76万 - 项目类别:
Targeting UHRF1 in combinational immunotherapy
联合免疫疗法中靶向 UHRF1
- 批准号:
10545165 - 财政年份:2019
- 资助金额:
$ 30.76万 - 项目类别:
Molecular determinants underlying herceptin sensitivity and resistance
赫赛汀敏感性和耐药性的分子决定因素
- 批准号:
8737478 - 财政年份:2014
- 资助金额:
$ 30.76万 - 项目类别:
相似海外基金
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 30.76万 - 项目类别:
Discovery Projects
Structural classification of NHEJ pathways; unravelling the role of Ku-binding proteins
NHEJ通路的结构分类;
- 批准号:
MR/X00029X/1 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Research Grant
BRC-BIO: Evolutionary Patterns of Ice-Binding Proteins in North Pacific Intertidal Invertebrates
BRC-BIO:北太平洋潮间带无脊椎动物冰结合蛋白的进化模式
- 批准号:
2312378 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Standard Grant
Exploring the roles and functions of sex steroid hormone receptor-associated RNA binding proteins in the development of geriatric diseases.
探索性类固醇激素受体相关 RNA 结合蛋白在老年疾病发展中的作用和功能。
- 批准号:
23K06408 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
膜结合蛋白的紫外等离子增强手性光谱
- 批准号:
10680969 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins
研究帕金森病蛋白 α-突触核蛋白和 RNA 结合蛋白之间的生理和病理生理联系
- 批准号:
10744556 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Structural and computational analysis of immune-related RNA-binding proteins
免疫相关 RNA 结合蛋白的结构和计算分析
- 批准号:
23K06597 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of carbohydrate-binding proteins and their applications
碳水化合物结合蛋白的表征及其应用
- 批准号:
23K05034 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A machine learning approach to identify carbon dioxide-binding proteins for sustainability and health
一种机器学习方法来识别二氧化碳结合蛋白以实现可持续发展和健康
- 批准号:
2838427 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别:
Studentship
The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
- 批准号:
10827567 - 财政年份:2023
- 资助金额:
$ 30.76万 - 项目类别: